PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mitochondrial dynamics in breast cancer metastasis: From metabolic drivers to therapeutic targets

2025-06-27
(Press-News.org) Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to its aggressive nature and limited therapeutic targets. Metabolic reprogramming, a hallmark of cancer, enables tumor cells to adapt to environmental stresses and fuel rapid proliferation. While the Warburg effect initially emphasized glycolysis, recent research highlights the critical role of mitochondrial oxidative metabolism in cancer progression. Mitochondria, dynamic organelles regulated by fission, fusion, and mitophagy, are central to metabolic plasticity, supporting tumor growth, metastasis, and therapy resistance. This review explores the molecular mechanisms of mitochondrial dynamics in breast cancer metastasis, their diagnostic and prognostic potential, and emerging therapeutic strategies targeting these pathways.

Mitochondrial Metabolism and Breast Cancer Plasticity
Metabolic heterogeneity is a defining feature of breast cancer, with TNBC exhibiting heightened reliance on fatty acid oxidation (FAO) and mitochondrial respiration to meet its energetic and biosynthetic demands. Key adaptations include:

Lipid Metabolism: Elevated FASN (fatty acid synthase) and ATP citrate lyase drive de novo lipogenesis, supporting membrane biogenesis and signaling.

Oxidative Phosphorylation (OXPHOS): Despite glycolytic dominance in primary tumors, metastatic lesions show increased TCA cycle flux and ATP production, underscoring mitochondrial metabolic flexibility.

Metabolic Shifts: Hypoxia and nutrient scarcity further rewire mitochondrial function, promoting survival and chemoresistance.

These adaptations highlight mitochondria as central hubs of metabolic reprogramming, offering vulnerabilities for therapeutic intervention.

Mitochondrial Fission, Fusion, and Mitophagy in Breast Cancer
Mitochondrial dynamics—governed by fission (Drp1, Fis1) and fusion (MFN1/2, OPA1) proteins—regulate cellular homeostasis and are dysregulated in cancer:

Fission: Promotes proliferation, stemness, and metastasis. Drp1 overexpression correlates with poor prognosis and is linked to Notch1-mediated chemoresistance in TNBC.

Fusion: Enhances OXPHOS and mitigates ROS. MFN2-PKM2 interactions suppress glycolysis, while OPA1 inhibition reduces tumor aggressiveness.

Mitophagy: Balances quality control and survival. PINK1/Parkin-mediated mitophagy eliminates damaged mitochondria, but its dual role—suppressing ROS or enabling stress adaptation—depends on context.

For example, BRCA1 deficiency disrupts mitophagy, elevating ROS and NLRP3 inflammasome activation, which drives metastasis. Conversely, mitophagy induction by compounds like polyphyllin I or silibinin triggers apoptosis in TNBC.

Mitochondrial Dynamics as Therapeutic Targets
Targeting mitochondrial dynamics shows promise in preclinical models:

Fission Inhibition: Mdivi-1 (Drp1 inhibitor) and P110 peptide reduce metastasis and restore chemosensitivity.

Fusion Promotion: Enhancing MFN2 activity suppresses glycolytic flux and tumor growth.

Mitophagy Modulation: Compounds like warangalone and kaempferol induce lethal mitophagy, while others (e.g., cepharanthine) block pro-survival pathways.

Table 1 summarizes key therapeutics, including cisplatin and flubendazole, which exploit mitochondrial vulnerabilities in TNBC.

Clinical Significance and Future Directions
Despite progress, challenges remain:

Heterogeneity: Mitochondrial adaptations vary by tumor subtype and stage, necessitating personalized approaches.

Drug Resistance: Metabolic plasticity may undermine targeted therapies, requiring combinatorial strategies.

Translational Gaps: Standardizing mitochondrial biomarkers (e.g., Drp1 levels) and improving drug delivery (e.g., nanoparticle carriers) are critical for clinical adoption.

Future research should integrate multi-omics to unravel metabolic-immune crosstalk and explore mitochondrial transplantation as a novel therapy.

Conclusion
Mitochondrial dynamics are pivotal in breast cancer metastasis, influencing metabolic flexibility, stemness, and therapy resistance. Targeting fission, fusion, and mitophagy offers a transformative approach to disrupt tumor adaptability. While challenges persist, advancing mitochondrial-directed therapies—combined with precision medicine tools—holds immense potential to improve outcomes for aggressive breast cancer subtypes.

 

Full text

https://www.xiahepublishing.com/2996-3427/OnA-2025-00001

 

The study was recently published in the Oncology Advances.

Oncology Advances is dedicated to improving the diagnosis and treatment of human malignancies, advancing the understanding of molecular mechanisms underlying oncogenesis, and promoting translation from bench to bedside of oncological sciences. The aim of Oncology Advances is to publish peer-reviewed, high-quality articles in all aspects of translational and clinical studies on human cancers, as well as cutting-edge preclinical and clinical research of novel cancer therapies.

Follow us on X: @xiahepublishing

Follow us on LinkedIn: Xia & He Publishing Inc.

END



ELSE PRESS RELEASES FROM THIS DATE:

Removing out-of-pocket fee improves access to 3D mammography

2025-06-27
A new study by UCLA researchers shows that removing a modest $45 out-of-pocket fee significantly improved access to digital breast tomosynthesis (3D mammography), an advanced breast cancer screening technology. Researchers found that eliminating the fee increased overall usage several percentage points and particularly benefited underserved patient populations, including racial and ethnic minorities and non-English speakers. The study appears in the Journal of the American College of Radiology. Why it matters Even small financial barriers can prevent patients from accessing potentially life-saving medical technology. ...

Does reducing exposure to image and video content on messaging apps reduce the impact of misinformation? Yes and no

2025-06-27
Elected officials, political analysts, and nonprofit organizations have for years spotlighted the spread of online election information in Western democracies—largely with a focus on media platforms popular in these nations, such as X and Facebook.  But in most of the world—notably the Global South—misinformation often reaches citizens through social messaging apps, including WhatsApp. Most often, falsehoods are shared on these platforms through multimedia content, such as easy-to-share videos and images.  Recognizing this, a team of researchers at New York University’s Center for Social Media and Politics (CSMaP) studied the behavior of WhatsApp users during ...

A global microbiome preservation effort enters its growth phase

2025-06-27
A global effort to create a “microbial Noah’s Ark” to preserve the world’s diverse collection of healthy microbes before they disappear is now entering an active growth phase. In a perspective article published in Nature Communications, a team of 25 scientists involved in the formation of the Microbiota Vault Initiative reported their successes and also laid out an ethical framework to ensure equitable collaboration and depositor sovereignty. This set of principles is designed to guide the initiative in its mission to safeguard microbial diversity for future generations. The announcement, which coincides with World Microbiome Day on June 27, marks ...

New credit card-sized TB test could close the diagnostic gap in HIV hotspots

2025-06-27
Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to sound the alarm. While more than 90% of the 2 billion TB cases worldwide are latent – symptom-free and not contagious – the weakening of the immune system in those with HIV can allow latent TB to turn active, increasing the potential for new infections to spread and often resulting in fatal outcomes. Tuberculosis is the leading cause of death among those with HIV worldwide. Now, Tulane University researchers have developed a new handheld TB test ...

A new blood test may detect leukemia risk and replace bone marrow sampling

2025-06-27
What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in-depth studies into the biology of blood to better understand the aging process and why some people become more susceptible to disease over the years. Their research teams, made up of physicians, biologists and data scientists, have been tracking changes in the blood-forming stem cells, including the emergence of genetic changes in these cells in about one-third of people over the age of 40. These changes not only increase ...

How the early heart develops

2025-06-27
The ion channel PIEZO2 doesn’t just convey touch stimuli. It also plays a key role in the development of coronary vessels, a team led by Annette Hammes from the Max Delbrück Center reports in “Nature Cardiovascular Research.” The findings could improve our understanding of congenital heart defects. Our skin can detect even the slightest breeze. This remarkable sensitivity is thanks to special ion channels embedded in cell membranes that respond to mechanical stimuli. Now a team led by Dr. Annette Hammes, Group Leader of the Molecular Signaling Pathways in Cortical Development lab at the Max Delbrück Center, has shown that one of these channels – ...

Releasing a molecular ‘brake’ may help immune cells better fight cancer

2025-06-27
GRAND RAPIDS, Mich. (June 27, 2025) — Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize dysfunctional or “exhausted” immune cells in their fight against cancer.   The target is an immune checkpoint called PTGIR, which regulates the number and cancer-fighting powers of T cells, the soldiers of the immune system. Too much PTGIR puts a brake on T cells and reduces their ability to release cancer-killing molecules.   The findings, published ...

Study identifies ways to lower risk of liver cancer for people with hepatitis B infection

2025-06-27
Hepatitis B virus (HBV) infection is known to be associated with the risk of hepatocellular carcinoma (HCC), but how and why they are connected remains unknown. Researchers from Mass General Brigham discovered that HBV does not cause liver inflammation or cancer on its own, but worsens liver inflammation and may make patients more susceptible to early cancer development caused by environmental carcinogens. Limiting carcinogen exposure or reducing inflammation could mitigate this risk. The results are published in Nature Communications.  “Our research sheds light on the intricate interplay between HBV infection and carcinogen exposure to generate immune dysregulation ...

Old termite mounds help support high insect biodiversity in tropical rainforests

2025-06-27
A new study by Dr Tom M. Fayle of Queen Mary University of London, Dr Kalsum M. Yusah of the Royal Botanic Gardens, Kew, and Dr Jiri Tuma of the Biology Centre of the Czech Academy of Sciences, Czech Republic, published today in the journal Soil Ecology Letters, shows the importance of old termite mounds as habitats for a wide range of insects and other invertebrates in Bornean tropical rainforest. Termites play a critical ecological role in many ecosystems. By building and maintaining their nests and mounds, they influence soil turnover, chemical soil properties, and nutrient distribution. Once these mounds are abandoned by their original ...

AI detects fatty liver disease with chest X-rays

2025-06-27
Fatty liver disease, caused by the accumulation of fat in the liver, is estimated to affect one in four people worldwide. If left untreated, it can lead to serious complications, such as cirrhosis and liver cancer, making it crucial to detect early and initiate treatment.  Currently, standard tests for diagnosing fatty liver disease include ultrasounds, CTs, and MRIs, which require costly specialized equipment and facilities. In contrast, chest X-rays are performed more frequently, are relatively ...

LAST 30 PRESS RELEASES:

RNA codon expansion via programmable pseudouridine editing and decoding

Post-diagnosis emergency department presentation and demographic factors in malignant skin cancers

A new genetic tuner for embryo development

Insurance churn and the COVID-19 pandemic

Postpartum Medicaid use in birthing parents and access to financed care

Manufacturing chemicals via orthogonal strategy, making full use of waste plastic resources in real life

Study overturns long-held belief about shape of fish schools

Precision oncology Organ Chip platform accurately and actionably predicts chemotherapy responses of patients suffering from esophageal adenocarcinoma

Verify the therapeutic effect of effective components of lycium barbarum on hepatocellular carcinoma based on molecular docking

Early intervention changes trajectory for depressed preschoolers

HonorHealth Research Institute presents ‘monumental’ increase in survivability for patients suffering ultra-low blood pressure

Mitochondrial dynamics in breast cancer metastasis: From metabolic drivers to therapeutic targets

Removing out-of-pocket fee improves access to 3D mammography

Does reducing exposure to image and video content on messaging apps reduce the impact of misinformation? Yes and no

A global microbiome preservation effort enters its growth phase

New credit card-sized TB test could close the diagnostic gap in HIV hotspots

A new blood test may detect leukemia risk and replace bone marrow sampling

How the early heart develops

Releasing a molecular ‘brake’ may help immune cells better fight cancer

Study identifies ways to lower risk of liver cancer for people with hepatitis B infection

Old termite mounds help support high insect biodiversity in tropical rainforests

AI detects fatty liver disease with chest X-rays

KIST develops high-performance memory devices that dissolve in water, addressing the E-waste problem

Tiny ocean migrants play a massive role in Southern Ocean carbon storage

Leafy greens could be good for the heart

How AI is making 2D materials stronger: An AI-driven framework to improve material design

Cascading impacts of groundwater input to coral reefs

Finding the enzymatic needle in the database haystack

In-line NMR guides orthogonal transformation of real-life plastics

Neopred: A dual-phase CT AI tool for preoperative prediction of pathological response in NSCLC

[Press-News.org] Mitochondrial dynamics in breast cancer metastasis: From metabolic drivers to therapeutic targets